Key Takeaways
- • David Layton transitions from sole CEO (appointed 2021) to chief investment officer and chairman, stepping down from day-to-day operational leadership in a planned succession move at Swiss private-markets manager Partners Group.
- • Roberto Cagnati and Juri Jenkner, both 20+ year Partners Group veterans, appointed as new co-CEOs, signaling continuity through internal promotion rather than external recruitment.
- • CEO shuffle follows redemption pressures and underperformance in flagship private equity funds, indicating stress in Partners Group's core investment vehicle amid broader private-market liquidity challenges.
- • Partners Group implementing redemption caps across additional private equity funds as the firm manages withdrawal requests from investors, particularly in European vehicles.
- • Pete Zippelius joins as co-head of Private Equity Health & Life Vertical in September 2026, reflecting ongoing portfolio and leadership restructuring at the firm.
Summary
Partners Group, the publicly listed Swiss private-markets investment firm (ticker: PGHN), has undertaken a significant leadership restructuring, moving CEO David Layton into the role of chief investment officer and chairman. Layton, who assumed sole CEO responsibilities in 2021 after serving as co-CEO since 2019, is stepping down from executive management in what the firm characterizes as a planned succession move.
The transition places Roberto Cagnati and Juri Jenkner into co-CEO positions. Both executives represent deep institutional continuity, having served Partners Group for more than 20 years. The internal promotion approach suggests the firm prioritized stability and embedded knowledge over external leadership recruitment—a notable choice given the operational challenges the firm currently faces.
The leadership change arrives amid demonstrated stress in Partners Group's private equity operations. Redemption requests have mounted in the firm's flagship and other European private equity vehicles, prompting management to implement withdrawal restrictions across a broader portfolio of funds. This points to performance headwinds in core investment operations that likely accelerated the succession timeline, moving it from theoretical planning to execution.
Concurrent with the CEO transition, the firm is advancing other leadership appointments. Pete Zippelius is joining Partners Group as co-head of the Private Equity Health & Life Vertical, effective September 2026, positioned at the firm's U.S. headquarters. This appointment underscores ongoing portfolio restructuring and suggests Partners Group is reinforcing sector-specific investment capabilities even as it manages redemption pressures.
The succession positions Layton to focus on investment strategy and governance as CIO and chairman—roles that may allow him to address the operational challenges facing flagship funds without the operational burden of day-to-day CEO duties. For institutional investors and limited partners, the outcome reflects both organizational resilience through internal succession and acknowledgment of performance headwinds requiring strategic recalibration.
The transition places Roberto Cagnati and Juri Jenkner into co-CEO positions. Both executives represent deep institutional continuity, having served Partners Group for more than 20 years. The internal promotion approach suggests the firm prioritized stability and embedded knowledge over external leadership recruitment—a notable choice given the operational challenges the firm currently faces.
The leadership change arrives amid demonstrated stress in Partners Group's private equity operations. Redemption requests have mounted in the firm's flagship and other European private equity vehicles, prompting management to implement withdrawal restrictions across a broader portfolio of funds. This points to performance headwinds in core investment operations that likely accelerated the succession timeline, moving it from theoretical planning to execution.
Concurrent with the CEO transition, the firm is advancing other leadership appointments. Pete Zippelius is joining Partners Group as co-head of the Private Equity Health & Life Vertical, effective September 2026, positioned at the firm's U.S. headquarters. This appointment underscores ongoing portfolio restructuring and suggests Partners Group is reinforcing sector-specific investment capabilities even as it manages redemption pressures.
The succession positions Layton to focus on investment strategy and governance as CIO and chairman—roles that may allow him to address the operational challenges facing flagship funds without the operational burden of day-to-day CEO duties. For institutional investors and limited partners, the outcome reflects both organizational resilience through internal succession and acknowledgment of performance headwinds requiring strategic recalibration.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.